It All Started With a Dream and Two Decades of Frustration

After over 20 years in clinical research, I had seen it all: brilliant investigators stalled by documentation delays, copy-paste errors buried in protocols, fragmented teams working in silos, and endless cycles of misalignment that caused trials to fail—not because of the science, but because of poor planning and execution.

For nearly two decades, I lived with that frustration—watching time, talent, innovation, and millions of dollars get wasted. So I decided to change it.

Angie Schwab, MS, PMP

Founder, Clinical Researcher, and Relentless Optimist

"What would happen if the world's best innovators were equipped with the most powerful clinical trial technology? We're finding out. And it's just the beginning."

What Guides Us

We're building more than a platform—we're reshaping how clinical trials are conducted. These principles guide everything we do.

🤝

Supercharging Collaboration

We believe groundbreaking research is a team effort. That's why we built Trialynx™—for seamless collaboration across teams, institutions, and time zones.

⚡

Simplifying Complexity

Clinical research is complex—your tools shouldn't be. We focus on intuitive, AI-powered workflows that make regulatory compliance easy.

🎯

Precision You Can Trust

Documents are not only generated—they're aligned, consistent, and ready from the start, using your templates, workflows, and formatting every time.

🔒

Security and Trust

Your data is our priority. Trialynx™ is built on secure infrastructure and adheres to global compliance standards to protect your research at every step.

Our Journey

2023

Trialynx™ is born

Trialynx is founded to solve the broken study start-up process.

2024

Expanding beyond startup

Expanded from protocol digitization to a full study development platform.

2026 Q1

Global accessibility & adaptive intelligence

We broaden access to under-resourced research communities and launch AI agents that adapt dynamically to study needs, participant diversity, and local regulations.

2026 Q3

Interoperability at scale

Trialynx becomes a fully integrated hub—connecting with CTMS, EDC, eTMF, and real-world data systems to power connected, compliant, digital trials across the globe.

2027

Human-AI symbiosis in research

Pioneering a new research era—where AI and human intelligence work in harmony to accelerate discovery, democratize access, and transform clinical trials worldwide.